CardioProlific

CardioProlific Overview

Founded 2010
Founded
Status Acquired/​Merged
Latest Deal Type M&A
Financing Rounds 1

CardioProlific General Information

Description

Developer of catheter-based thrombectomy system intended to treat peripheral vascular disease. The company's catheter-based thrombectomy system develops new approaches to improve re-stenosis in Peripheral Arterial Disease (PAD) and offers clinically effective non-implant solution utilizing patented Ultrasound Technology that changes media/intima calcium compliance and facilitates therapeutic drugs penetration to the vessel wall.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Acquirer
Primary Office
  • 26062 Eden Landing Road
  • Suite 10
  • Hayward, CA 94545
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CardioProlific Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CardioProlific‘s full profile, request access.

Request a free trial

CardioProlific Executive Team (2)

Name Title Board Seat Contact Info
Henry Nita Co-Founder, Treasurer, Chief Executive Officer, President & Secretary
Michael Wallace Co-Founder